I think a very important thing at this point is the publication of the Faro's research paper. I am sure the session was recorded since they were doing it on DVD and that will be something I have little doubt the company will begin sending to targeted people. That will make a difference, but once the technical results on the N-Assay are published everything should start to move.

The Neonatal and Sepsis panels that we were told are being tested should be incredible product leaders for the company.

As to timing based on what I heard I would guess 6-9 months but there is no way to know. But from public information we know that Texas Medical knows about the products, Battelle thinks it is a leader, the EPA continues to work with the NanoLogix technology (although a government agency is a CYA-do-nothing actor more often than not), the packaging has great implications for military field conditions medical uses. As I indicated, I am trying to do a market analysis that I hope to post next week.